In today’s recent session, 1.54 million shares of the Metagenomi Inc (NASDAQ:MGX) have been traded, and its beta is -0.56. Most recently the company’s share price was $2.24, and it changed around $0.33 or 17.28% from the last close, which brings the market valuation of the company to $83.74M. MGX at last check was trading at a discount to its 52-week high of $5.50, offering almost -145.54% off that amount. The share price’s 52-week low was $1.23, which indicates that the recent value has risen by an impressive 45.09% since then. We note from Metagenomi Inc’s average daily trading volume that its 10-day average is 0.9 million shares, with the 3-month average coming to 458.59K.
Metagenomi Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.33. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended MGX as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight.
Metagenomi Inc (NASDAQ:MGX) trade information
Instantly MGX has been showing a green trend so far today with a performance of 17.28% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.3499 on recent trading dayincreased the stock’s daily price by 4.68%. The company’s shares are currently down -46.15% year-to-date, but still up 47.85% over the last five days. On the other hand, Metagenomi Inc (NASDAQ:MGX) is 29.48% up in the 30-day period. We can see from the shorts that 2.1 million shares have been sold at a short interest cover period of 5.57 day(s).
The consensus price target as assigned by Wall Street analysts is $14.5, which translates to bulls needing to increase their stock price by 84.55% from its current value. Analyst projections state that MGX is forecast to be at a low of $7 and a high of $22.
Metagenomi Inc earnings are expected to increase by -3.60% in 2025, but the outlook is negative -14.66% per year for the next five years.
MGX Dividends
Metagenomi Inc’s next quarterly earnings report is expected to be released on 2025-May-13.
Metagenomi Inc (NASDAQ:MGX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 28.20% of Metagenomi Inc shares, and 26.49% of them are in the hands of institutional investors. The stock currently has a share float of 36.90%. Metagenomi Inc stock is held by 104.0 institutions, with NOVO HOLDINGS A/S being the largest institutional investor. By 2024-06-30, it held 4.9146% of the shares, which is about 1.8 million shares worth $7.34 million.
RA CAPITAL MANAGEMENT, L.P., with 4.0348% or 1.48 million shares worth $6.03 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF were the top two Mutual Funds as of Mar 31, 2025 . The former held 760.0 shares worth $1.67 million, making up 2.03% of all outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held roughly 650.35 shares worth around $1.43 million, which represents about 1.74% of the total shares outstanding.
